Response to letter of Vahle et al.
Jolette
Jacquelin
J
Wilker
Clynn E
CE
Fox
John
J
D000818:Animals; D015197:Carcinogenicity Tests / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D009374:Neoplasms, Experimental / Q000139:chemically induced* / Q000453:epidemiology; D010281:Parathyroid Hormone / Q000493:pharmacokinetics / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000633:toxicity; D018570:Risk Assessment; D019379:Teriparatide / Q000633:toxicity
D010281:Parathyroid Hormone; D011994:Recombinant Proteins; D019379:Teriparatide